Tag: Samsung Biologics
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Samsung Biologics to manufacture Moderna’s COVID-19 vaccine in South Korea
Global biotechnology company Moderna has inked a manufacturing services and supply agreement with Samsung Biologics under which the South Korea-based contract development and manufacturing...
Featured Article
“New Starts Here”: AGHA launches national platform for gift and homewares
Australia’s peak organisation for the gift and homewares sector, the Australian Gift & Homewares Association (AGHA), has revealed plans for a major expansion in 2026, introducing Gifted Melbourne 2026 to complement the long-established AGHA Sydney Gift Fair.
